PetVivo announces study results involving Spryng

PetVivo Holdings announced that Alexander Amalfitano DVM, of Ethos Veterinary Health and Colorado Animal Specialty & Emergency presented at the Veterinary Orthopedic Society annual conference on the completion of the first cohort of dogs in a clinical study, which examined the benefit and tolerability of an intra-articular injection of collagen-elastin hydrogel microparticles into the coxofemoral joint of dogs with osteoarthritis. The dogs enrolled in this study had been diagnosed with unilateral or bilateral coxofemoral joint osteoarthritis. Nine dogs have completed the study to date. At day 84, 7 of 9 patients had a greater than 3-point reduction in total CBPI score, and 7 of 9 patients had improved hip extension on goniometry. All 9 patients had improved visual lameness scores and quality of life assessments In summary, this study demonstrates that Spryng may be a viable alternative for medical management of dogs with coxofemoral joint osteoarthritis.